Join us as we continue our review of the top 10 practice gaps of 2018, first presented at last year's update course by Apps's Practice Development Committee. Number seven. Alex. So number seven is Venus Thromboembolism prophylaxis in high risk trauma patients. So they found that for low bleeding risk patients, it's okay to just do uh, SCDs and low molecular weight heparin. And for high bleeding risk patients, uh, they recommend SCDs and they're until they're ambulatory, and then a screening ultrasound on ICU day seven. So basically, if they're high risk for bleeding, you're leaving out the the low molecular weight heparin. Correct. Okay. Great.
Click "Show Transcript" to view the full transcription (652 characters)
Comments